PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 7 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | +200.0% | 57,659 | +182.6% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 20,402 | -52.2% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 42,659 | +90.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 22,457 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 22,457 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 22,457 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 22,457 | +3.7% | 0.00% | – |
| Q2 2020 | $1,000 | – | 21,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,226,961 | $221,000 | 0.02% |
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $10,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 1,077,555 | $107,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 79,500 | $8,000 | 0.00% |
| Virtu KCG Holdings LLC | 364,520 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 81,647 | $8,000 | 0.00% |
| WADE G W & INC | 80,000 | $8,000 | 0.00% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 29,358 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,500 | $0 | 0.00% |